Difference between revisions of "TMG Meaningful Use"
From VistApedia
(→Q: What about the required Clinical Quality Measures (CQM)?) |
(→Q: What about the required Clinical Quality Measures (CQM)?) |
||
| Line 104: | Line 104: | ||
[http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/CQM_EPs_2012_02_02.pdf Click here for a list of all measures afrom the CMS website along with the instructions just above.] | [http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/CQM_EPs_2012_02_02.pdf Click here for a list of all measures afrom the CMS website along with the instructions just above.] | ||
| + | |||
| + | NB: If you see the numerator and denomiator logic filled out, it means that the measure is fully supported in the Quality Measurement Package. If they are not there, then they are unsupported; you may still report on them, but you will have to do extra work on your end to make them work. | ||
==== Core Measures ==== | ==== Core Measures ==== | ||
{| class="wikitable" | {| class="wikitable" | ||
| Line 131: | Line 133: | ||
| NQF 0038||Childhood immunization status||[http://www.qualityforum.org/QPS/MeasureDetails.aspx?standardID=395&print=0&entityTypeID=1 details]|| Patients <= 2 yo || Dialog MU NQF0038 IMMUNE MANAGEMENT DI | | NQF 0038||Childhood immunization status||[http://www.qualityforum.org/QPS/MeasureDetails.aspx?standardID=395&print=0&entityTypeID=1 details]|| Patients <= 2 yo || Dialog MU NQF0038 IMMUNE MANAGEMENT DI | ||
|} | |} | ||
| − | + | ==== Additional Core Measures ==== | |
| − | + | An additional '''3 from a list of 38 CQM's''' must be reported. | |
| − | + | {| class="wikitable" | |
| − | + | |- | |
| + | ! Measure !! Description !! Sources !! Denominator in VISTA !! Numerator in VISTA | ||
| + | |- | ||
| + | | NQF0059 || Diabetes: Hemoglobin A1c Poor Control || [http://www.qualityforum.org/QPS/MeasureDetails.aspx?standardID=1225&print=0&entityTypeID=1 details] || Diabetics via Meds or Diagnosis || Lab HEMOGLOBIN A1C or Health Factor PQRI HBA1C>9 MK | ||
| + | |- | ||
| + | | NQF0061 || Diabetes: Low Density Lipoprotein (LDL) Management and Control || [http://www.qualityforum.org/QPS/MeasureDetails.aspx?standardID=1228&print=0&entityTypeID=1 details] || Diabetics via Meds or Diagnosis || Lab LDL CHOLESTEROL or Health Factor PQRI LDL < 100 | ||
| + | |- | ||
| + | | NQF0064 || Diabetes: Blood Pressure Management || [http://www.qualityforum.org/QPS/MeasureDetails.aspx?standardID=1235&print=0&entityTypeID=1 details] || Diabetics via Meds or Diagnosis || Blood Pressure entered via Vitals Package. | ||
| + | |} | ||
| + | |||
| + | *# -- | ||
| + | *# Diabetes: Blood Pressure Management | ||
*# Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) [http://www.qualityforum.org/QPS/MeasureDetails.aspx?standardID=383&print=0&entityTypeID=1 details] | *# Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) [http://www.qualityforum.org/QPS/MeasureDetails.aspx?standardID=383&print=0&entityTypeID=1 details] | ||
*# Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) [http://www.qualityforum.org/QPS/MeasureDetails.aspx?standardID=377&print=0&entityTypeID=1 details] | *# Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) [http://www.qualityforum.org/QPS/MeasureDetails.aspx?standardID=377&print=0&entityTypeID=1 details] | ||
Revision as of 23:38, 1 October 2012
Contents
- 1 Outpatient Meaningful Use for WorldVistA
- 1.1 Q: Where can I find the certification status of WorldVistA?
- 1.2 Q: There seems to be so many steps to be ready to attest meaningful use. It's overwhelming. Any overview sites?
- 1.3 Q: What's the bottom line? What do I have to do to be ready to attest meaningful use?
- 1.4 Q: Can you tell me more about the 15 "core" meaningful use measures? (all are required)
- 1.5 Q: What about the 5 "menu" set of meaningful use objectives? (5 of 10 possible are required)
- 1.6 Q: What about the required Clinical Quality Measures (CQM)?
Outpatient Meaningful Use for WorldVistA
Hello. My name is Kevin Toppenberg, MD. I am a primary care physician in Greeneville, TN. I have been active in the VistA community for at least 7 years, and have used VistA in my office during this time. I have decided to pursue meaningful use certification with VistA. This page will document my progress towards this, and record notes that I make to myself along the way. I hope this is helpful to others.
In CMS terminology, I am an "Eligible Provider" (EP), not a hospital. Also, I am going after Medicare (not Medicaid) certification. So my discussion below will be targeted accordingly.
NOTE: Other are welcome to make enhancements to this page
Q: Where can I find the certification status of WorldVistA?
- Go to CMS Certified Health IT Products
- Search for "WorldVistA" -- NOTE: the search engine on this page is flaky. I found that when I clicked the search button, it would return a list of ALL technology. But when I then simply clicked search AGAIN (with WorldVistA still in the search term box), then it would find it.
Q: There seems to be so many steps to be ready to attest meaningful use. It's overwhelming. Any overview sites?
- I recommend starting with this overview: CMS EHR Meaningful Use Overview. The information I am posting here is from this site.
- Alternatively, here are the slides from a CMS webinar presentation.
- Here is another CMS document (2010) document with similar detail.
- A very good presentation from IHS giving an overview of Meaningful Use can be found here
Q: What's the bottom line? What do I have to do to be ready to attest meaningful use?
- Meet 20 of 25 "Meaningful Use Objectives" source
- Must meet 15 "core" measures
- Must also meet 5 of 10 possible "menu" set measures
- Meet 6 of 41 "Clinical Quality Measures (CQM's)" source
- Must meet 3 required core quality measures
- must also meet 3 of 38 possible additional quality measures
- Attest to meeting requirements using Y/N answers and by supplying data from the Quality Measures package.
TODO SMH: Reference and write about the Quality Measures package.
Q: Can you tell me more about the 15 "core" meaningful use measures? (all are required)
(Detailed instructions on meeting these will be provided in more detail below.)
| Measure | Link to CMS Source | VISTA fulfillment | Attestation Type |
|---|---|---|---|
| CPOE -- Provider directly enters in orders | Source | Fulfillment | Rate > 30% |
| Implement drug-drug and drug-allergy interaction checks | Source | Fulfillment | Yes/No |
| Maintain an up-to-date problem list of current and active diagnoses | Source | Fullfillment | Rate > 80% |
| Generate and transmit permissible prescriptions electronically (eRx) | Source | not available | Rate > 40% |
| Maintain active medication list | Source | Fulfillment | Rate > 80% |
| Maintain active medication allergy list | Source | Fulfillment | Rate > 80% |
| Record required demographics | Source | Fulfillment | Rate > 50% |
| Record required vital signs | Source | Fulfillment | Rate > 50% |
| Record smoking status for patients aged 13 yrs and up | Source | Fulfillment | Rate > 50% |
| Report clinical quality measures to CMS | Source | Fulfillment | Yes/No (Measures are reportable rates however) |
| Implement 1 clinical decision support rule | Source | Fulfillment | Yes/No |
| Provide patients with an electronic copy of their health information | Source | Fulfillment | Rate > 50% |
| Provide clinical summaries for patients for each office visit within 3 days | Source | Fulfillment | Rate > 50% |
| Perform at least 1 test of exchanging key clinical information with another entity electronically | Source | Fulfillment | Yes/No |
| Protect electronic health information | Source | Yes/No |
| Measure | Link to CMS Source | VISTA fulfillment | Attestation Type |
|---|---|---|---|
| Implement drug formulary checks | Source | Fulfillment | Yes/No |
| Incorporate lab results into EHR as structured data | Source | Fulfillment | Rate > 40% |
| Generate list of patients by specific conditions for quality improvement | Source | Fulfillment | Yes/No |
| Send patient reminders per patient preference | Source | NOT DONE | NOT DONE |
| Provide patients with timely electronic access to their health information | Source | NOT DONE | NOT DONE |
| Provide patient-specific education resources | Source | Fulfillment | Rate > 10% |
| Perform medication reconcilliation | Source | Fulfillment | Rate > 50% |
| Send summary care record to other providers | Source | Fulfillment | Rate > 50% |
| Submit data to immunization registries | Source | Fulfillment | Yes/No |
| Submit syndromic surveillance data | Source | NOT DONE | NOT DONE |
Q: What about the required Clinical Quality Measures (CQM)?
You must report the 3 core measures. If any of the 3 core measures are reported with zero values for the denominator, you are required to pick an alternate core measure to report in addition, even if these yield zero. For example if: NQF 0028 & NQF 0421 are 0; report 2 measures from the alternate core measures.
In addition to the core/alternate core measures, you need to report an additional 3 measures from the additional list of 38 CQMs.
Click here for a list of all measures afrom the CMS website along with the instructions just above.
NB: If you see the numerator and denomiator logic filled out, it means that the measure is fully supported in the Quality Measurement Package. If they are not there, then they are unsupported; you may still report on them, but you will have to do extra work on your end to make them work.
Core Measures
| Measure | Description | Sources | Denominator in VISTA | Numerator in VISTA |
|---|---|---|---|---|
| NQF0013 | Hypertension: Blood Pressure Measurement | details2 | Patients with Hypertenstion | Blood Pressure recorded as a Vital |
| NQF0028 | Tobacco: Use Asessment | details | Patients | Health factors in NFQ0028AB Tobacco Managment Dialog |
| Tobacco Cessation Intervention | details | Patients who smoke | Health factors in NFQ0028AB Tobacco Managment Dialog | |
| NQF0421 | Adult Weight Screening and Follow-up | details | Patients with high BMI | Health factors in MU NQF0421 BMI DI |
Alternate Core Measures
If you reported 0 for all 3 core measures, you must report on all 3 alternate core measures even if you will report zeroes for all 6 measures.
| Measure | Description | Sources | Denominator in VISTA | Numerator in VISTA |
|---|---|---|---|---|
| NQF 0024 | BMI for age 2-18 | details | Obese Patients in the Date Range (using Vitals package) | ICD9/CPT codes V65.3, 97802, G0270, S9449, S9452, S9470 |
| NQF 0041 | Influenza vaccination | details | Patients | Immunization (IM FLU, 3 yrs) in MU NQF0041 INFLUENZA MANAGEMENT DI |
| NQF 0038 | Childhood immunization status | details | Patients <= 2 yo | Dialog MU NQF0038 IMMUNE MANAGEMENT DI |
Additional Core Measures
An additional 3 from a list of 38 CQM's must be reported.
| Measure | Description | Sources | Denominator in VISTA | Numerator in VISTA |
|---|---|---|---|---|
| NQF0059 | Diabetes: Hemoglobin A1c Poor Control | details | Diabetics via Meds or Diagnosis | Lab HEMOGLOBIN A1C or Health Factor PQRI HBA1C>9 MK |
| NQF0061 | Diabetes: Low Density Lipoprotein (LDL) Management and Control | details | Diabetics via Meds or Diagnosis | Lab LDL CHOLESTEROL or Health Factor PQRI LDL < 100 |
| NQF0064 | Diabetes: Blood Pressure Management | details | Diabetics via Meds or Diagnosis | Blood Pressure entered via Vitals Package. |
- --
- Diabetes: Blood Pressure Management
- Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) details
- Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) details
- Pneumonia Vaccination Status for Older Adults details
- Breast Cancer Screening details
- Colorectal Cancer Screening details
- Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD details
- Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) details
- Anti-depressant medication management: (a) Effective Acute Phase Treatment, (b)Effective Continuation Phase Treatment details
- Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation details
- Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy details
- Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care details
- Asthma Pharmacologic Therapy details
- Asthma Assessment details
- Appropriate Testing for Children with Pharyngitis details
- Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer details
- Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients details
- Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients details
- Smoking and Tobacco Use Cessation, Medical Assistance: a) Advising Smokers and Tobacco Users to Quit, b) Discussing Smoking and Tobacco Use Cessation Medications, c) Discussing Smoking and Tobacco # Use Cessation Strategies details
- Diabetes: Eye Exam details
- Diabetes: Urine Screening details
- Diabetes: Foot Exam details
- Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol details
- Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation -- NQF 0084
- Ischemic Vascular Disease (IVD): Blood Pressure Management details
- Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic details
- Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: a) Initiation, b) Engagement details
- Prenatal Care: Screening for Human Immunodeficiency Virus (HIV) -- NQF 0012
- Prenatal Care: Anti-D Immune Globulin -- NQF 0014
- Controlling High Blood Pressure details
- Cervical Cancer Screening details
- Chlamydia Screening for Women details
- Use of Appropriate Medications for Asthma details
- Low Back Pain: Use of Imaging Studies details
- Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control details
- Diabetes: Hemoglobin A1c Control (<8.0%) details
